NY A11279 | 2017-2018 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on July 25 2018 - 25% progression, died in committee
Action: 2018-07-25 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.

Sponsors


History

DateChamberAction
2018-07-25Assemblyreferred to health

Same As/Similar To

S07710 (Same As) 2018-06-19 - referred to health

New York State Sources


Bill Comments

feedback